Sarris, Jerome
Sinclair, Justin
Karamacoska, Diana
Davidson, Maggie
Firth, Joseph
Article History
Received: 22 January 2019
Accepted: 15 December 2019
First Online: 16 January 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: <b>JS1</b> and <b>JS2</b> conduct cannabis research as university members of the Australia Medicinal Cannabis Research and Education Collaboration (ExternalRef removed). <b>JS1</b> has received consultancy payment from a cannabis manufacturing company as an independent scientific advisor (Australian Natural Therapeutics Group); this was however received many months after the creation and submission of this publication and was unrelated to this manuscript. He has also received either presentation honoraria, travel support, clinical trial grants, book royalties, or independent consultancy payments from: Integria Healthcare & MediHerb, Pfizer, Scius Health, Key Pharmaceuticals, Research Reviews, Taki Mai, Fiji Kava, Bioceuticals & Blackmores, Soho-Flordis, Healthworld, HealthEd, HealthMasters, Kantar Consulting, Elsevier, Chaminade University, International Society for Affective Disorders, Complementary Medicines Australia, SPRIM, Terry White Chemists, ANS, Society for Medicinal Plant and Natural Product Research, Sanofi-Aventis, Omega-3 Centre, the National Health and Medical Research Council, CR Roper Fellowship. <b>JS2</b> has sat on the Scientific Advisory Board for BioCeuticals.